Foghorn Therapeutics  logo
Foghorn Therapeutics FHTX
€ 1.56 -4.47%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 09.11.2026

Foghorn Therapeutics Gesamtes Eigenkapital | FHTX

Gesamtes Eigenkapital Jährlich Foghorn Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-108 M -45.5 M -77.2 M 112 K 96.9 M 146 M -88 M - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
146 M -108 M -10.9 M

Gesamtes Eigenkapital Vierteljährlich Foghorn Therapeutics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-14.1 M -81 M -76.4 M -108 M -89.7 M -76.7 M -61.7 M -45.5 M -28.3 M -14.3 M -97.5 M -77.2 M -57.4 M -49.4 M -24.6 M 112 K 24.3 M 47.6 M 72.4 M 96.9 M 81 M 104 M 125 M 146 M -133 M 146 M 146 M -88 M -88 M -61.3 M - -39.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
146 M -133 M -10.4 M

Gesamtes Eigenkapital anderer Aktien in der Pharmaeinzelhändler

Name Gesamtes Eigenkapital Preis % 24h Marktkapitalisierung Land
Lyra Therapeutics Lyra Therapeutics
LYRA
-10.7 M - - $ 24.9 M usaUSA
Brickell Biotech Brickell Biotech
BBI
9.93 M - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
57 M - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
125 M - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
86.2 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
-38.9 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
648 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
190 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
212 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
63.9 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
-27.2 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
3.24 B - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
7.16 M - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.83 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
15.8 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
21.5 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
154 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
27.3 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
98.7 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
4.16 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
57.4 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
928 M - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
-473 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
2.53 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
11.8 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
750 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
205 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
78.4 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
8.15 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
46.8 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
234 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
156 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
15.1 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
163 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
-4.08 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
-914 K - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
-8.44 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
-45.3 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
6.12 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
188 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
176 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
-31.5 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
31.8 M - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
44.6 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
-11.9 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
39.1 M - - $ 728 M usaUSA